Synagis Dosing Change Stirs Up Controversy: Florida, Idaho stick with 2006 Red Book.

Recommended changes in the prophylactic use of palivizumab for some premature babies at risk of respiratory syncytial virus in the 2009 Red Book continue to stir controversy, with at least one state chapter of the American Academy of Pediatrics, as well as Florida Medicaid deciding to stick with the 2006 Red Book recommendations.